Sandoz on Thursday launched telmisartan tablets, the generic version of Micardis from Boehringer Ingelheim. The drug is used to treat hypertension, the company said.
Mylan announced the launch of telmisartan tablets USP, which is used to treat hypertension.
Roxane Labs announced the launch of telmisartan tablets USP, an authorized generic version of Boehringer Ingelheim's Micardis tablets.
In line with American Heart Month, Boehringer Ingelheim's Micardis has introduced a cardiovascular risk-reduction calculator, designed to assess patients' cardiovascular risk.
An investigational treatment for Type 2 diabetes by Boehringer Ingelheim Pharmaceuticals significantly lowered blood sugar,...